Harish Poptani Selected Research

Harish Poptani Research Topics

Disease

33	Neoplasms (Cancer) 10/2023 - 01/2003
8	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 11/2010
8	Brain Neoplasms (Brain Tumor) 04/2021 - 11/2010
7	Glioma (Gliomas) 01/2021 - 03/2009
6	Squamous Cell Carcinoma of Head and Neck 11/2022 - 06/2002
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2011 - 08/2008
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2013 - 12/2007
3	Head and Neck Neoplasms (Head and Neck Cancer) 06/2013 - 09/2009
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2011 - 02/2009
2	Hypoxia (Hypoxemia) 01/2024 - 01/2013
2	Neoplasm Metastasis (Metastasis) 10/2023 - 11/2010
2	Central Nervous System Diseases (CNS Diseases) 04/2016 - 03/2014
2	Lymphoma (Lymphomas) 11/2010 - 05/2007
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2010 - 10/2008
2	Fibrosarcoma 12/2003 - 04/2003
1	Body Weight (Weight, Body) 03/2024
1	Intellectual Disability (Idiocy) 02/2024
1	Neurodevelopmental Disorders 02/2024
1	Microcephaly 02/2024
1	Melanoma (Melanoma, Malignant) 10/2023
1	Brain Diseases (Brain Disorder) 01/2019
1	Neuroblastoma 01/2018
1	Breast Neoplasms (Breast Cancer) 03/2017
1	Kidney Diseases (Kidney Disease) 11/2016
1	Carcinogenesis 04/2015
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Autism Spectrum Disorder 01/2014
1	Necrosis 07/2011
1	Fucosidosis 08/2010
1	Oligodendroglioma 01/2010
1	alpha-Mannosidosis 01/2010
1	Astrocytoma (Pilocytic Astrocytoma) 01/2010
1	Motor Disorders 01/2010
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2010
1	Ischemia 12/2009

Drug/Important Bio-Agent (IBA)

13	Protons (Proton)IBA 01/2019 - 01/2003
10	Biomarkers (Surrogate Marker)IBA 10/2023 - 09/2007
10	Lactic Acid (Lactate)FDA LinkGeneric 01/2011 - 01/2003
8	Choline (Choline Chloride)IBA 03/2017 - 12/2007
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011 - 04/2003
6	LipidsIBA 10/2019 - 05/2005
5	Choline KinaseIBA 01/2024 - 04/2015
5	Vincristine (Oncovin)FDA LinkGeneric 01/2011 - 12/2007
5	Prednisone (Sone)FDA LinkGeneric 01/2011 - 12/2007
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2024 - 11/2009
4	CreatineIBA 01/2017 - 11/2010
3	NucleosidesIBA 09/2013 - 12/2007
3	Glucose (Dextrose)FDA LinkGeneric 12/2003 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 10/2023
2	alpha-hydroxyglutarateIBA 06/2017 - 09/2016
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2017 - 09/2016
2	1,4- (4- 4'- Bis- ((4- (dimethylamine)pyridinium- 1- yl) methyl)diphenyl)butane dibromideIBA 03/2017 - 04/2015
2	Phosphorylcholine (Phosphocholine)IBA 04/2015 - 04/2003
2	Glutamic Acid (Glutamate)FDA Link 08/2014 - 12/2003
2	Inositol (Myoinositol)IBA 10/2013 - 11/2010
2	triphosphoric acid (triphosphate)IBA 01/2011 - 12/2007
2	Rituximab (Mabthera)FDA Link 01/2011 - 04/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011 - 12/2007
2	bryostatin 1IBA 11/2008 - 12/2007
2	Indicators and Reagents (Reagents)IBA 08/2008 - 09/2007
2	Perchloric AcidIBA 12/2003 - 04/2003
1	Therapeutic UsesIBA 03/2024
1	Matrix Metalloproteinases (MMPs)IBA 10/2023
1	IpilimumabIBA 10/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	Chimeric Antigen ReceptorsIBA 01/2019
1	epidermal growth factor receptor VIIIIBA 01/2019
1	IronIBA 01/2018
1	Green Fluorescent ProteinsIBA 01/2018
1	EnzymesIBA 09/2016
1	Alginic AcidIBA 04/2016
1	PolyethyleneimineIBA 04/2016
1	ChitosanIBA 04/2016
1	Poly(amidoamine)IBA 04/2016
1	Antimitotic AgentsIBA 01/2016
1	APTIBA 01/2015
1	CathepsinsIBA 08/2014
1	Peptide Hydrolases (Proteases)FDA Link 08/2014
1	neuroligin 3IBA 01/2014
1	phosphorylethanolamine (phosphoethanolamine)IBA 09/2013
1	Phosphorus (Red Phosphorus)IBA 09/2013
1	Oxygen (Dioxygen)IBA 01/2013
1	Phosphates (Orthophosphate)IBA 01/2011
1	N-acetylaspartate (N-acetyl aspartate)IBA 11/2010
1	FucoseIBA 08/2010
1	SugarsIBA 08/2010
1	OligosaccharidesIBA 01/2010
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2010
1	UbiquitinIBA 01/2010
1	alpha-Mannosidase (LAMAN)IBA 01/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2009

Therapy/Procedure

17	Therapeutics 01/2024 - 01/2003
8	Drug Therapy (Chemotherapy) 02/2020 - 06/2002
5	Radiotherapy 02/2020 - 06/2002
2	Induction Chemotherapy 11/2022 - 10/2011
2	Immunotherapy 04/2021 - 04/2009
2	Aftercare (After-Treatment) 04/2015 - 04/2009
2	Combination Drug Therapy (Combination Chemotherapy) 11/2008 - 12/2007
1	Cranial Irradiation 01/2015
1	Time-to-Treatment 09/2013